Welcome! If you have a coupon code, click here to apply it. Apply

URGN $0.00 ( +0.00%) Quote details

stock

UroGen Pharma Ltd

NASDAQ | URGN

7.37

USD

+0.00 ( +0.00%)

AT CLOSE (AS OF Jun 6, 2025)

$340M

MARKET CAP

-

P/E Ratio

-3.01

EPS

$21

52 Week High

$3.4

52 Week Low

LIFE SCIENCES

Sector

URGN Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

URGN Technicals

Tags:

URGN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $82M
Total Revenue $90M
Cost Of Revenue $8.9M
Costof Goods And Services Sold $8.9M
Operating Income -$97M
Selling General And Administrative $121M
Research And Development $57M
Operating Expenses $178M
Investment Income Net -
Net Interest Income -$3.6M
Interest Income $8.9M
Interest Expense $13M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$124M
Income Tax Expense $2.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$127M
Comprehensive Income Net Of Tax -
Ebit -$112M
Ebitda -$110M
Net Income -$127M

Revenue & Profitability

Earnings Performance

URGN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $286M
Total Current Assets $276M
Cash And Cash Equivalents At Carrying Value $172M
Cash And Short Term Investments $172M
Inventory $9.2M
Current Net Receivables $20M
Total Non Current Assets $9.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $5M
Short Term Investments $65M
Other Current Assets $9.9M
Other Non Current Assets -
Total Liabilities $295M
Total Current Liabilities $46M
Current Accounts Payable $11M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $249M
Capital Lease Obligations $1.7M
Long Term Debt $122M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $123M
Other Current Liabilities $41M
Other Non Current Liabilities -
Total Shareholder Equity -$8.8M
Treasury Stock -
Retained Earnings -$806M
Common Stock $115K
Common Stock Shares Outstanding $43M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$97M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.2M
Capital Expenditures $295K
Change In Receivables -
Change In Inventory -$3.6M
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $195M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$127M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $82M
Total Revenue $90M
Cost Of Revenue $8.9M
Costof Goods And Services Sold $8.9M
Operating Income -$97M
Selling General And Administrative $121M
Research And Development $57M
Operating Expenses $178M
Investment Income Net -
Net Interest Income -$3.6M
Interest Income $8.9M
Interest Expense $13M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$124M
Income Tax Expense $2.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$127M
Comprehensive Income Net Of Tax -
Ebit -$112M
Ebitda -$110M
Net Income -$127M

URGN News

URGN Profile

UroGen Pharma Ltd Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

None

NCNA
26.33%
$0.0499
PLUG
11.21%
$0.9692
APLD
8.54%
$13.86
DNN
3.70%
$1.68
TSLA
3.67%
$295.14
NVDA
1.24%
$141.72
LCID
0.94%
$2.15
HCTI
-1.52%
$0.0065
F
1.58%
$10.26
GNLN
-5.71%
$0.0066
NCL
-80.74%
$0.26
PLTR
6.51%
$127.72
QBTS
13.05%
$18.62
INTC
0.35%
$20.06
AXDX
-61.36%
$0.034
HOOD
3.27%
$74.88
SOFI
4.17%
$14.24
BTG
-1.61%
$3.67
DTCK
33.98%
$0.8039
VERO
33.05%
$3.18
MARA
6.05%
$15.78
RXRX
20.13%
$5.49
GLYC
-2.42%
$0.1938
FAAS
40.20%
$0.7181
RIOT
9.57%
$9.85
LYT
-16.78%
$0.0982
PHAT
90.19%
$8.92
RIG
2.60%
$2.76
JWN
0.08%
$24.66
AAL
4.53%
$11.78
PCG
-1.82%
$15.64
BTE
4.09%
$1.78
TGB
17.69%
$3.06
WULF
13.58%
$4.35
BNAI
23.38%
$0.57
AAPL
1.64%
$203.92
VHAI
11.11%
$0.0006
NVTS
2.15%
$6.18
AG
-1.66%
$8.27
HIMS
6.75%
$56.33
ACHR
8.87%
$10.19
AVGO
-5.00%
$246.93
AMZN
2.72%
$213.57
EYEN
55.41%
$4.88
RGTI
3.58%
$11.28
CLF
7.04%
$7.6
WBUY
54.35%
$7.1
BAC
1.92%
$44.97
BJDX
48.03%
$2.25
GOOGL
3.25%
$173.68
QUBT
15.81%
$13.7
RKLB
9.34%
$28.92
CAN
3.69%
$0.5989
IAG
-3.13%
$7.44
GRAB
2.17%
$5.17
NGD
-2.04%
$4.8
BBD
0.00%
$2.89
SOUN
6.76%
$10.11
MLGO
-8.00%
$1.15
HL
-2.79%
$6.27
DFS
-0.21%
$200.05
NIO
0.28%
$3.63
CLSK
8.54%
$9.79
HBAN
3.05%
$16.22
PFE
0.99%
$23.35
ABEV
1.22%
$2.49
WBD
1.76%
$9.82
ME
-21.26%
$0.6063
CHPT
10.37%
$0.7472
CUTR
-10.19%
$0.0969
TLRY
4.48%
$0.4056
VALE
-0.11%
$9.49
JOBY
7.41%
$8.12
KLTO
5.07%
$0.205
LGMK
5.00%
$0.0042
AMD
0.43%
$116.19
CHGG
34.71%
$1.63
IREN
8.94%
$9.75
SNAP
0.85%
$8.27
FSM
-3.65%
$7.13
SMCI
1.91%
$41.55
AGNC
0.00%
$9.04
RIVN
1.60%
$14
UBER
1.09%
$85.59
ITUB
0.61%
$6.56
ONDS
7.59%
$1.7
EXK
-1.32%
$4.49
AFMD
-34.95%
$0.1815
CRWV
3.78%
$140.16
MRVL
4.90%
$68.35
EQX
-5.06%
$6.94
CIFR
10.48%
$3.9
DOCU
-18.97%
$75.28
KGC
-2.39%
$15.09
T
1.15%
$28.08
GOOG
3.01%
$174.92
CSCO
2.23%
$66.06
URGN
43.39%
$7.37
MU
2.14%
$108.56
IOVA
13.89%
$2.05
NCNA
26.33%
$0.0499
PLUG
11.21%
$0.9692
APLD
8.54%
$13.86
DNN
3.70%
$1.68
TSLA
3.67%
$295.14
NVDA
1.24%
$141.72
LCID
0.94%
$2.15
HCTI
-1.52%
$0.0065
F
1.58%
$10.26
GNLN
-5.71%
$0.0066
NCL
-80.74%
$0.26
PLTR
6.51%
$127.72
QBTS
13.05%
$18.62
INTC
0.35%
$20.06
AXDX
-61.36%
$0.034
HOOD
3.27%
$74.88
SOFI
4.17%
$14.24
BTG
-1.61%
$3.67
DTCK
33.98%
$0.8039
VERO
33.05%
$3.18
MARA
6.05%
$15.78
RXRX
20.13%
$5.49
GLYC
-2.42%
$0.1938
FAAS
40.20%
$0.7181
RIOT
9.57%
$9.85
LYT
-16.78%
$0.0982
PHAT
90.19%
$8.92
RIG
2.60%
$2.76
JWN
0.08%
$24.66
AAL
4.53%
$11.78
PCG
-1.82%
$15.64
BTE
4.09%
$1.78
TGB
17.69%
$3.06
WULF
13.58%
$4.35
BNAI
23.38%
$0.57
AAPL
1.64%
$203.92
VHAI
11.11%
$0.0006
NVTS
2.15%
$6.18
AG
-1.66%
$8.27
HIMS
6.75%
$56.33
ACHR
8.87%
$10.19
AVGO
-5.00%
$246.93
AMZN
2.72%
$213.57
EYEN
55.41%
$4.88
RGTI
3.58%
$11.28
CLF
7.04%
$7.6
WBUY
54.35%
$7.1
BAC
1.92%
$44.97
BJDX
48.03%
$2.25
GOOGL
3.25%
$173.68
QUBT
15.81%
$13.7
RKLB
9.34%
$28.92
CAN
3.69%
$0.5989
IAG
-3.13%
$7.44
GRAB
2.17%
$5.17
NGD
-2.04%
$4.8
BBD
0.00%
$2.89
SOUN
6.76%
$10.11
MLGO
-8.00%
$1.15
HL
-2.79%
$6.27
DFS
-0.21%
$200.05
NIO
0.28%
$3.63
CLSK
8.54%
$9.79
HBAN
3.05%
$16.22
PFE
0.99%
$23.35
ABEV
1.22%
$2.49
WBD
1.76%
$9.82
ME
-21.26%
$0.6063
CHPT
10.37%
$0.7472
CUTR
-10.19%
$0.0969
TLRY
4.48%
$0.4056
VALE
-0.11%
$9.49
JOBY
7.41%
$8.12
KLTO
5.07%
$0.205
LGMK
5.00%
$0.0042
AMD
0.43%
$116.19
CHGG
34.71%
$1.63
IREN
8.94%
$9.75
SNAP
0.85%
$8.27
FSM
-3.65%
$7.13
SMCI
1.91%
$41.55
AGNC
0.00%
$9.04
RIVN
1.60%
$14
UBER
1.09%
$85.59
ITUB
0.61%
$6.56
ONDS
7.59%
$1.7
EXK
-1.32%
$4.49
AFMD
-34.95%
$0.1815
CRWV
3.78%
$140.16
MRVL
4.90%
$68.35
EQX
-5.06%
$6.94
CIFR
10.48%
$3.9
DOCU
-18.97%
$75.28
KGC
-2.39%
$15.09
T
1.15%
$28.08
GOOG
3.01%
$174.92
CSCO
2.23%
$66.06
URGN
43.39%
$7.37
MU
2.14%
$108.56
IOVA
13.89%
$2.05
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.